203 related articles for article (PubMed ID: 37133704)
41. Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine.
Ghys LF; Meyer E; Paepe D; Delanghe J; Daminet S
Vet Clin Pathol; 2014 Jun; 43(2):226-34. PubMed ID: 24773065
[TBL] [Abstract][Full Text] [Related]
42. Repeated measurements of renal function in evaluating its decline in cats.
Finch NC; Syme HM; Elliott J
J Feline Med Surg; 2018 Dec; 20(12):1144-1148. PubMed ID: 29451445
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
Coyne MJ; Schultze AE; McCrann DJ; Murphy RE; Cross J; Strong-Townsend M; Drake C; Mack R
PLoS One; 2022; 17(5):e0269085. PubMed ID: 35622875
[TBL] [Abstract][Full Text] [Related]
44. REPEATABILITY AND RELIABILITY OF GLOMERULAR FILTRATION RATE DETERMINATION VIA GAMMA CAMERA UPTAKE OF TC-99M-DTPA IN CATS WITH CHRONIC KIDNEY DISEASE.
Felumlee AE; Marolf AJ; Randall EK; Bachand AM; Quimby JM
Vet Radiol Ultrasound; 2017 Jan; 58(1):90-99. PubMed ID: 27774745
[TBL] [Abstract][Full Text] [Related]
45. Quantitative renal scintigraphic determination of the glomerular filtration rate in cats with normal and abnormal kidney function, using 99mTc-diethylenetriaminepentaacetic acid.
Uribe D; Krawiec DR; Twardock AR; Gelberg HB
Am J Vet Res; 1992 Jul; 53(7):1101-7. PubMed ID: 1497177
[TBL] [Abstract][Full Text] [Related]
46. Changes in renal function in cats following treatment of hyperthyroidism using 131I.
Adams WH; Daniel GB; Legendre AM; Gompf RE; Grove CA
Vet Radiol Ultrasound; 1997; 38(3):231-8. PubMed ID: 9238796
[TBL] [Abstract][Full Text] [Related]
47. Short-term evaluation of renal markers in overweight adult cats.
Pérez-López L; Boronat M; Melián C; Santana A; Brito-Casillas Y; Wägner AM
Vet Med Sci; 2023 Mar; 9(2):572-578. PubMed ID: 36639961
[TBL] [Abstract][Full Text] [Related]
48. Comparison of creatinine and cystatin formulae with
Cholongitas E; Ioannidou M; Goulis I; Chalevas P; Ntogramatzi F; Athanasiadou Z; Notopoulos A; Alevroudis M; Sinakos E; Akriviadis E
J Gastroenterol Hepatol; 2017 Jan; 32(1):191-198. PubMed ID: 27177318
[TBL] [Abstract][Full Text] [Related]
49. Assessment of Kidney Graft Function Evolution Measured by Creatinine and Cystatin C.
Ramos-Barron MA; Hernandez Bejarano I; Rodrigo E; Cruz Iglesias E; Benito Hernandez A; Agueros Blanco C; Morales Martin AI; Prieto Vicente M; Lopez Hernandez F; Arias M; Gomez-Alamillo C
Transplant Proc; 2016 Nov; 48(9):2913-2916. PubMed ID: 27932106
[TBL] [Abstract][Full Text] [Related]
50. Does intravenous contrast medium administration result in altered renal biomarkers? A study in clinically stable cats with and without azotemia.
Prüllage ML; Schwendenwein I; Eberspächer-Schweda E; Kneissl S
J Feline Med Surg; 2022 Jun; 24(6):565-579. PubMed ID: 34493101
[TBL] [Abstract][Full Text] [Related]
51. Relationship of glomerular filtration rate based on serum iodixanol clearance to IRIS staging in cats with chronic kidney disease.
Iwama R; Sato T; Katayama M; Shimamura S; Satoh H; Ichijo T; Furuhama K
J Vet Med Sci; 2015 Aug; 77(8):1033-5. PubMed ID: 25864431
[TBL] [Abstract][Full Text] [Related]
52. Renal scintigraphy predicts global cardiovascular risk in hypertensive subjects with normal serum creatinine levels.
Mazza A; Rampin L; Montemurro D; Schiavon L; Zuin M; Grassetto G; Chondrogiannis S; Al-Nahhas A; Ramazzina E; Rubello D
Blood Press; 2011 Dec; 20(6):387-93. PubMed ID: 22017389
[TBL] [Abstract][Full Text] [Related]
53. Absence of renal cortical anisotropic backscattering artifact in feline chronic kidney disease.
Chou PH; Heng HG; Lin FJ; Chen KS
Vet Q; 2021 Dec; 41(1):210-216. PubMed ID: 34112054
[TBL] [Abstract][Full Text] [Related]
54. Impact of allogeneic feline uterine-derived mesenchymal stromal cell intravenous treatment on renal function of nephrectomized cats with chronic kidney disease.
Zacharias S; Welty MB; Sand TT; Black LL
Res Vet Sci; 2021 Dec; 141():33-41. PubMed ID: 34653723
[TBL] [Abstract][Full Text] [Related]
55. Cystatin C: a new renal marker and its potential use in small animal medicine.
Ghys L; Paepe D; Smets P; Lefebvre H; Delanghe J; Daminet S
J Vet Intern Med; 2014; 28(4):1152-64. PubMed ID: 24814357
[TBL] [Abstract][Full Text] [Related]
56. Renal shear wave elastography and urinary procollagen type III amino-terminal propeptide (uPIIINP) in feline chronic kidney disease.
Thanaboonnipat C; Sutayatram S; Buranakarl C; Choisunirachon N
BMC Vet Res; 2019 Feb; 15(1):54. PubMed ID: 30744640
[TBL] [Abstract][Full Text] [Related]
57. Prospective evaluation of healthy Ragdoll cats for chronic kidney disease by routine laboratory parameters and ultrasonography.
Paepe D; Bavegems V; Combes A; Saunders JH; Daminet S
J Feline Med Surg; 2013 Oct; 15(10):849-57. PubMed ID: 23413268
[TBL] [Abstract][Full Text] [Related]
58. Improved glomerular filtration rate estimation using new equations combined with standardized cystatin C and creatinine in Chinese adult chronic kidney disease patients.
Guo X; Qin Y; Zheng K; Gong M; Wu J; Shou W; Cheng X; Xia L; Xu E; Li X; Qiu L
Clin Biochem; 2014 Sep; 47(13-14):1220-6. PubMed ID: 24886770
[TBL] [Abstract][Full Text] [Related]
59. [Clinical application of full age spectrum formula based on serum creatinine in patients with chronic kidney disease].
Huang S; Wu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):877-881. PubMed ID: 30309415
[TBL] [Abstract][Full Text] [Related]
60. Analytical quality performance goals for symmetric dimethylarginine in cats.
Baral RM; Freeman KP; Flatland B
Vet Clin Pathol; 2021 Mar; 50(1):57-61. PubMed ID: 33524207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
